TITLE

Diabetes: Monitoring and counseling patients with prediabetes and type 2 diabetes

AUTHOR(S)
Dang, Devra K.
PUB. DATE
November 2011
SOURCE
Drug Topics;Nov2011, Vol. 155 Issue 11, p51
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Approximately 26 million Americans are currently diagnosed with diabetes, and another 79 million have been diagnosed with pre-diabetes, at a total cost to the economy of more than $175 billion per year. The prevalence of type 2 diabetes has been rising in parallel with the rates of obesity, and these trends highlight the growing importance of early detection of individuals with risk factors for diabetes such as obesity, physical inactivity, hypertension, cardiovascular disease, and elevated blood serum levels of glucose and lipids. Complications of diabetes are numerous and severe: In addition to sensory and autonomic neuropathy they include diabetic retinopathy and diabetic nephropathy -- the leading causes of blindness and kidney failure. While first-line therapy emphasizes nutrition therapy, exercise, and weight loss, medical interventions have also proven effective. These include medications to control hyperglycemia, dyslipidemia, and hypertension, as well as bariatric surgery. The pharmacist is in a unique position to play a critical role in diabetes care, by counseling patients in self-monitoring techniques, by helping to ensure that patients adhere to their prescribed medication regimens, by educating patients about adverse drug reactions, and by playing a central role in medication therapy management. The Asheville Project and Diabetes Ten-City Challenge demonstrated that a multimodal approach -- including counseling, self-monitoring, lifestyle changes, and appropriate medication -- can significantly reduce the risk of diabetes and the costs associated with both its treatment and its economic effects.
ACCESSION #
67664240

 

Related Articles

  • Getting Complicated.  // Countdown;Spring2000, Vol. 21 Issue 2, p8 

    Expounds on diabetes complications. Possible development of heart, kidney, eye and nerve problems; Damage caused by excess blood glucose on body cells; Prevention of complications; Treatment of diabetic retinopathy, nephropathy and neuropathy.

  • Fibrates and Microvascular Complications in Diabetes - Insight from the FIELD Study. Ansquer, J. C.; Foucher, C.; Aubonnet, P.; Le Malicot, K. // Current Pharmaceutical Design;2/11/2009, Vol. 15 Issue 5, p537 

    Fibrates are widely prescribed lipid-lowering drug in the treatment of dyslipidemia. Their main clinical effects, mediated by peroxisome proliferative activated receptor (PPAR) alpha activation, are a moderate reduction in total cholesterol and low-density lipoprotein cholesterol (LDL-C) levels,...

  • Protection From Retinopathy and Other Complications in Patients With Type 1 Diabetes of Extreme Duration. SUN, JENNIFER K.; KEENAN, HILLARY A.; CAVALLERANO, JERRY D.; ASZTALOS, BELA F.; SCHAEFER, ERNST J.; SELL, DAVID R.; STRAUCH, CHRISTOPHER M.; MONNIER, VINCENT M.; DORIA, ALESSANDRO; AIELLO, LLOYD PAUL; KING, GEORGE L. // Diabetes Care;Apr2011, Vol. 34 Issue 4, p968 

    OBJECTIVE--To assess complication prevalence and identify protective factors in patients with diabetes duration of ≥50 years. Characterization of a complication-free subgroup in this cohort would suggest that some individuals are protected from diabetes complications and allow...

  • Retinal Vascular Caliber as a Biomarker for Diabetes Microvascular Complications. IKRAM, M. KAMRAN; CHEUNG, CAROL Y.; LORENZI, MARA; KLEIN, RONALD; JONES, TERESA L. Z.; WONG, TIEN YIN // Diabetes Care;Mar2013, Vol. 36 Issue 3, p750 

    The article examines retinal vascular caliber as a potential biomarker for retinopathy, nephropathy and neuropathy, the three major microvascular complications of diabetes. It describes the current status of early biomarkers for diabetes complications. A discussion of the abnormalities of...

  • The UCLA Interdepartmental Conference. Brown, Josiah; Straatsma, Bradley R.; Apt, Leonard; Christensen, Robert E.; Foos, Robert Y.; Gordon, Arthur; Latta, Harrison; Pettit, Thomas H.; Rand, Robert W.; Roth, Nathan H. // Annals of Internal Medicine;Mar68, Vol. 68 Issue 3, p634 

    Discusses issues related to diabetes, which were presented at the Interdepartmental Conference of the University of California in Los Angeles in 1968. Etiology of diabetes; Clinical aspects of diabetic nephropathy; Information on diabetic retinopathy.

  • Prevalence of Other Micro and Macrovascular Complications of Diabetes Among Asian Indian Subjects with Diabetic Retinopathy The Chennai Urban Rural Epidemiology [CURES] Eye Study. Rema, Mohan; Pradeepa, Rajendra; Premkumar, Sundaram; Deepa, Raj; Mohan, Viswanathan // Diabetes;Jun2007 Supplement 1, Vol. 56, pA218 

    The aim of the present study was to estimate the prevalence of two microvascular [neuropathy and nephropathy] and two macrovascular [coronary artery disease (CAD) and peripheral vascular diseases (PVD)] complications in Asian Indian type 2 diabetic subjects with diabetic retinopathy (DR)....

  • Demonstration of Islet Cell Function in Patients with 50 years or Longer of Diabetes. Keenan, Hillary A.; Berger, Alysha; Sun, Jennifer K.; Eisenbarth, George; Doria, Alessandro; King, George L. // Diabetes;Jun2007 Supplement 1, Vol. 56, pA386 

    In 1972, Joslin Diabetes Center began awarding a medal to individuals (Medalists) who had documented insulin dependent diabetes for 50 or more years. To date, 218 have been enrolled in the Medalist Study, with a mean current age of 68 ±7.1 years, average age at diagnosis of 12.4 ±7 years,...

  • Relationship Between Diabetic Microangiopathy and Vascular Endothelial Function Assessed by Flow-Mediated Vasodilatation in Patients with Type 2 Diabetes. Suetsugu, Mariko; Takebayashi, Kohzo; Saaso, Yoshima; Inukai, Toshihiko // Diabetes;Jun2007 Supplement 1, Vol. 56, pA583 

    This study was designed to investigate the relationship between vascular endothelial function and diabetic microangiopathy (nephropathy, retinopathy, and neuropathy) in patients with type 2 diabetes. Furthermore, the association between endothelial function and macroangiopathy evaluated by...

  • Lipid Mediators Are Critical in Resolving Inflammation: A Review of the Emerging Roles of Eicosanoids in Diabetes Mellitus. Tessaro, Fernando H. G.; Ayala, Thais S.; Martins, Joilson O. // BioMed Research International;3/19/2015, Vol. 2015, p1 

    The biosynthesis pathway of eicosanoids derived from arachidonic acid, such as prostaglandins and leukotrienes, relates to the pathophysiology of diabetes mellitus (DM). A better understanding of how lipid mediators modulate the inflammatory process may help recognize key factors underlying the...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics